NCT04849494

Brief Summary

Background: It is increasingly recognized that late preterm infants have increased respiratory morbidity in the neonatal period as well as decreased lung function in later life. Also, in-utero growth retardation (IUGR) and low birth weight are associated with increased respiratory morbidity beginning from infancy, throughout childhood and into adulthood. However, very few studies have assessed long term respiratory consequences of late preterm birth in comparison with IUGR. Aim: To determine respiratory morbidity of late-preterm vs infants with IUGR at school age Study Design: Participants included late-preterm AGA infants (34-36, 6/7 weeks), IUGR infants (term/preterm) and term AGA infants born between 2004 and 2008 were included in this study and assessed for respiratory morbidity at school age. To assess the impact of late-preterm birth compared with IUGR and term gestation on respiratory morbidity by using a validated questionnaire. Wheezing, infectious respiratory morbidity and physician-diagnosed asthma panels were evaluated.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2011

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2013

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2014

Completed
7 years until next milestone

First Submitted

Initial submission to the registry

April 13, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 19, 2021

Completed
Last Updated

April 19, 2021

Status Verified

April 1, 2021

Enrollment Period

3 years

First QC Date

April 13, 2021

Last Update Submit

April 13, 2021

Conditions

Keywords

Premature BirthLate pretermFetal Growth RetardationAsthmaSchool-age

Outcome Measures

Primary Outcomes (1)

  • to evaluate respiratory morbidity of late preterm and IUGR newborns at school age

    between 5 to 7 years of age

Secondary Outcomes (1)

  • to point out the effects of risk factors encountered in the neonatal period for respiratory morbidity at school age

    between 5 to 7 years of age

Study Arms (3)

Late preterm AGA infants/Group 1

According to the new BALLARD scoring system gestational age was 34-36 6/7 and those who were at the 10-90th percentile according to the Fenton growth curves

Other: ATS-DLD-78-C and ISAAC questionnaires

Newborns with Intrauterine growth restriction/Group 2

Term or preterm infants below 10th percentile according to the values calculated according to Fenton growth curves

Other: ATS-DLD-78-C and ISAAC questionnaires

Control/Group 3

the healthy term (gestation week 38-42 weeks), AGA newborns, who born between January 2006 and December 2008

Other: ATS-DLD-78-C and ISAAC questionnaires

Interventions

Early, natal and postnatal period data were recorded from the hospital database system and patient file. The morbidities observed during the follow-up of the newborns, the duration of hospitalization, needed of oxygen, surfactant administration, positive pressure ventilation requirement, and need for mechanical ventilation support and duration were noted from patient file records. Anthropometric measurements of all patients were taken. Demographic information, socioeconomic level, mother/father education level, mother's smoking status and medical history were questioned, and physical examinations of the patients were performed. were performed for screening respiratory diseases. After the physical examination, the validated Turkish forms of ATS-DLD-78-C and ISAAC questionnaires were filled in face-to-face by the research doctor who did not know the patients' medical history

Control/Group 3Late preterm AGA infants/Group 1Newborns with Intrauterine growth restriction/Group 2

Eligibility Criteria

Age5 Years - 7 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

A total number of 160 children were included in the study. Children who admitted to the Neonatal intensive care unit and/or those who were born at the obstetrics unit and followed up with their mothers between January 2006 - December 2008 and reevaluated at school age (5-7 years old) during the study, were divided into two main groups: Late preterm AGA infants: according to the new BALLARD scoring system gestational age was 34-36 6/7 and those who were at the 10-90th percentile according to the Fenton growth curves. Newborns with IUGR: term or preterm infants below 10th percentile according to the values calculated according to Fenton growth curves. And, the healthy term (gestation week 38-42 weeks), AGA newborns, who born between January 2006 and December 2008, were included in the study as a control group

You may qualify if:

  • Children who admitted to the Neonatal intensive care unit and/or those who were born at the obstetrics unit and followed up with their mothers between January 2006 - December 2008 and reevaluated at school age (5-7 years old) during the study.
  • None of major anomalies,
  • Patients who come to the school-age assessment
  • Accept the informed consent form

You may not qualify if:

  • The presence of major anomalies,
  • Patients who did not come to the school-age assessment
  • Rejected the informed consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Fetal Growth RetardationPremature BirthAsthma

Condition Hierarchy (Ancestors)

Fetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGrowth DisordersPathologic ProcessesPathological Conditions, Signs and SymptomsObstetric Labor, PrematureObstetric Labor ComplicationsBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2021

First Posted

April 19, 2021

Study Start

January 1, 2011

Primary Completion

December 30, 2013

Study Completion

March 30, 2014

Last Updated

April 19, 2021

Record last verified: 2021-04